Drug Roundup: New FDA-Approved Treatments in Rheumatology
In this slideshow, we offer a glance at newly approved treatments for rheumatoid arthritis, juvenile arthritis, osteoporosis and fingernail psoriasis, among other conditions.
Here’s What You Should Know about Axial Spondyloarthritis
Chronic back pain, arthritis and enthesitis are among common axSpA manifestations, but no two patients are alike. Here, we highlight key presentations.
Axial Spondyloarthritis Guidelines Updated and Simplified
EULAR-ASAS have updated the 2010 guidelines for axSpA emphasizing treat to target, tapering and for the first time, cost considerations.
Axial Spondyloarthritis Treatment Recommendations
In this slideshow, we highlight the 13 ASAS-EULAR treatment management guidelines for axial spondyloarthritis.
FUNCTION Trial 2-Year Results for Tocilizumab in Early RA
Early stage RA treated with tocilizumab or tocilizumab and methotrexate realized clinical benefits with no safety concerns at two years.
Steroids Pose Infection Risk During Pregnancy
Research shows that for women with autoimmune disease, the increase risk of infection during pregnancy is associated with steroids, not DMARDs.
Under Treatment and Over Treatment Common in JIA
Estimates for juvenile idiopathic arthritis differ widely depending on which set of criteria doctors use.
By clicking Accept, you agree to become a member of the UBM Medica Community.